首页/数据集/Supplementary Data from Proteasome Subunits Differentially Control Myeloma Cell Viability and Proteasome Inhibitor Sensitivity

Supplementary Data from Proteasome Subunits Differentially Control Myeloma Cell Viability and Proteasome Inhibitor Sensitivity

NIAID Data Ecosystem2026-04-25 收录

多发性骨髓瘤治疗

激酶抑制剂敏感性

数据链接：

https://figshare.com/articles/dataset/Supplementary_Data_from_Proteasome_Subunits_Differentially_Control_Myeloma_Cell_Viability_and_Proteasome_Inhibitor_Sensitivity/22514248 数据链接链接失效反馈

官方服务：

资源简介：

Ten end stage patients.

应用场景：

创建时间：

2020-10-01

医疗成本分析

多发性骨髓瘤治疗

Supplementary Figure 1 . Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system This table contains the Anatomical The

DataCite Commons2024-05-16 更新90

The HDAC inhibitor LBH589 enhances the anti-myeloma effect of the IGF-1 RTK inhibitor picropodophyllin (PPP). Homo sapiens

多发性骨髓瘤治疗

细胞凋亡机制

Our previous studies have shown that inhibition of the IGF-1R pathway by the IGF-1RTK inhibitor picropodophyllin (PPP) can be achieved and also constitutes a favorable therapeutic window in multiple m

NIAID Data Ecosystem30

The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma

多发性骨髓瘤治疗

硼替佐米

IntroductionBortezomib has significantly improved multiple myeloma (MM) response rates, but strategies for choosing bortezomib-based regimens for initial MM therapy are not standardized. Here, we desc

Figshare2016-01-15 更新00

Patient characteristics and clinical features.

多发性骨髓瘤治疗

自体干细胞移植

ABSCT: autologous stem cell transplantation AUY: NVP-AUY922 BPT: bortezomib, prednisone and thalidomide Dexa: dexamethasone HD-Melphalan: high dose melphalan MPV: melphalan, prednisone and bortezomib

NIAID Data Ecosystem60

Additional file 2 of Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice

多发性骨髓瘤治疗

生存预后

Additional file 2: Supplementary Table 2a. Association of OS with selected variables. Supplementary Table 2b Association of OS with selected variables in multivariable analysis – Paired analysis.

Figshare2021-01-16 更新20

Supplementary Data from Proteasome Subunits Differentially Control Myeloma Cell Viability and Proteasome Inhibitor Sensitivity

资源简介：

相关数据集